Cantitate/Preț
Produs

Primary Central Nervous System Tumors: Pathogenesis and Therapy: Current Clinical Oncology

Editat de Andrew D. Norden, David A. Reardon, Patrick C. Y. Wen
en Limba Engleză Paperback – 28 ian 2013
This comprehensive, yet practical, text is a ready collection of the most up-to-date information on primary CNS tumors. Authored by a carefully selected group of the world’s leading clinicians and scientists, the book is divided into three sections. The opening chapters cover general principles, including epidemiology, pathogenesis, tumor stem cells, supportive care, complications of therapy, and quality of life. The remaining two sections are comprised of treatment-oriented chapters covering the spectrum of gliomas and rarer tumor types. Each of these chapters presents multi-disciplinary therapeutic approaches and addresses specific disease concerns. Throughout, the authors incorporate the cutting-edge advances in molecular biology and genomics that are revolutionizing neuro-oncology. The result is an important clinical resource which provides evidence-based data and interpretation essential to intelligent therapeutic decision making.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 153346 lei  6-8 săpt.
  Humana Press Inc. – 28 ian 2013 153346 lei  6-8 săpt.
Hardback (1) 136677 lei  6-8 săpt.
  Humana Press Inc. – 15 dec 2010 136677 lei  6-8 săpt.

Din seria Current Clinical Oncology

Preț: 153346 lei

Preț vechi: 161417 lei
-5% Nou

Puncte Express: 2300

Preț estimativ în valută:
29349 31161$ 24311£

Carte tipărită la comandă

Livrare economică 26 decembrie 24 - 09 ianuarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781617797231
ISBN-10: 1617797235
Pagini: 584
Ilustrații: XIV, 570 p.
Dimensiuni: 155 x 235 x 31 mm
Greutate: 0.81 kg
Ediția:2011
Editura: Humana Press Inc.
Colecția Humana
Seria Current Clinical Oncology

Locul publicării:Totowa, NJ, United States

Public țintă

Professional/practitioner

Cuprins

Part I: General Principles.- 1 - Epidemiology and Risk Factors.- 2 - Molecular Pathogenesis.- 3 - Brain Tumor Stem Cells.- 4 - Principles of Supportive Care.- 5 - Principles of Clinical Trial Design and Response Assessment.- 6 - Complications of Therapy.- 7 – Neuropsychological Function and Quality of Life.- Part II: Gliomas.- 8 - Low-Grade Gliomas.- 9 - High-Grade Astrocytomas.- 10 - Anaplastic Oligodendrogliomas and Mixed Gliomas.- 11 - Ependymomas.- 12 - Uncommon Gliomas in Adults: Brainstem Gliomas, Pilocytic Astrocytomas and Pleomorphic Xanthoastrocytomas.- Part III: Other Tumor Types.- 13 - Pediatric Tumors.- 14 - Primary Central Nervous System Lymphoma.- 15 - Meningiomas.- 16 - Pituitary Adenomas.- 17 - Vestibular Schwannomas.- 18 - Medulloblastomas.- 19 - Pineal Region Tumors.- 20 - Genetic Syndromes.- 21 - Rare Tumors.- 22 - Spinal Tumors.

Recenzii

From the reviews:
“In this compendium of current literature on brain tumors and treatment paradigms, the chapters are well written by experts in the field who present the information in a concise and clinically applicable format. … It is written for clinicians involved in the care of patients with brain tumors. … which is to provide a readable and thorough resource on CNS tumors for practicing physicians.” (Mark K. Lyons, Doody’s Review Service, February, 2011)

Textul de pe ultima copertă

This comprehensive, yet practical, text is a ready collection of the most up-to-date information on primary CNS tumors. Authored by a carefully selected group of the world’s leading clinicians and scientists, the book is divided into three sections. The opening chapters cover general principles, including epidemiology, pathogenesis, tumor stem cells, supportive care, complications of therapy, and quality of life. The remaining two sections are comprised of treatment-oriented chapters covering the spectrum of gliomas and rarer tumor types. Each of these chapters presents multi-disciplinary therapeutic approaches and addresses specific disease concerns. Throughout, the authors incorporate the cutting-edge advances in molecular biology and genomics that are revolutionizing neuro-oncology. The result is an important clinical resource which provides evidence-based data and interpretation essential to intelligent therapeutic decision making.

Caracteristici

A comprehensive, yet practical, treatment-oriented text for physicians caring for primary brain tumor patients Features editors and authors from the most esteemed treatment centers Includes supplementary material: sn.pub/extras